Leverkusen, Germany -- Bayer MaterialScience AG has invested Euro 2.3 million in a new production line at Dormagen, Germany, for its Baycusan range of waterborne polyurethane dispersions (PUDs) for cosmetic and medical uses.
The new facility, part of the PUD plant at the Dormagen Chempark, will produce polyurethane dispersions of maximum purity, which will be sold to the cosmetics industry as Baycusan C. These PU dispersions comply with the high quality and purity requirements in cosmetic and medical uses: they contain no co-solvents or preservatives, said Bayer.
"For us, innovation and investment are key to sustainable growth," said Dr Joachim Wolff, head of Coatings, Adhesives, Specialties (CAS) at Bayer MaterialScience, in a 21 April statement from the group.
Wolff said the project, completed in less than two years, exemplifies BMS' innovation strategy. "To enable us to deliver more success stories, we will invest around 30 percent more in research projects and customer-related developments this year than we did in 2007," he added.
BMS introduced Baycusan at the In-Cosmetics trade fair in April 2008, and has since distributed several hundred samples to potential customers in the cosmetics industry. "The interest has been considerable. Now the business can really start to meet the needs of the market," said Dr Steffen Hofacker, who is head of Cosmetics at Bayer MaterialScience.
The new facility has been designed to be completely germ-free and, thanks to a special BMS-developed process, it needs no co-solvents such as NMP (N-methylpyrrolidone) or ethanol. The cosmetics industry "can use these dispersions safely in all cosmetic applications," said Hofacker.
At Dormagen, BMS said, it is preparing the next stage: launching a Baycusan product line for the medical market.